Table 5. Correlation of OCT4, SOX2, and NANOG Expression with Clinicopathological Features.
| Parameters | Age | Gender (male) | Pathological grade | Tumor size | T stage | N stage | M stage | TNM stage |
|---|---|---|---|---|---|---|---|---|
| OCT4 expression | ||||||||
| R | −0.122 | 0.155 | 0.185* | 0.224* | 0.143 | 0.170* | −0.013 | 0.091 |
| p value | 0.133 | 0.055 | 0.022* | 0.005* | 0.077 | 0.036* | 0.875 | 0.264 |
| SOX2 expression | ||||||||
| R | −0.023 | −0.054 | 0.079 | 0.047 | −0.126 | 0.045 | −0.109 | −0.113 |
| p value | 0.774 | 0.506 | 0.329 | 0.561 | 0.121 | 0.583 | 0.182 | 0.163 |
| NANOG expression | ||||||||
| R | −0.012 | −0.056 | −0.124 | 0.169* | −0.051 | 0.139 | −0.094 | 0.062 |
| p value | 0.887 | 0.491 | 0.128 | 0.036* | 0.534 | 0.087 | 0.249 | 0.450 |
OCT4, octamer-binding transcription factor 4; SOX2, sex determining region Y-box 2; NANOG, Nanog homebox.
Data was presented as correlation index R and p value. Correlation was determined by Pearson test.
*p<0.05 was considered significant.